Further participation from existing investors raised additional €7 million
Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from...
Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic vision system...
Nevro touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain.
Redwood City, Calif.-based Nevro, which published the...
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial....
Ava, a digital healthcare company that focuses on women's reproductive health, has announced it will be launching the first study of its kind to test...
Clinical trial results for Insulet's Omnipod 5 automated insulin pump system showed improvements across multiple metrics after three months of use for adult, adolescent and pediatric...
Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan® , the first and only patient-friendly, preparation-free, screening test to detect polyps...
Study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin Scale
BrainQ, the...
Abbott (NYSE:ABT) has halted a clinical trial comparing its HeartMate II ventricular assist device with the Abiomed (NSDQ:ABMD) Impella heart pumps.
The Abbott Park, Ill.-based company suspended enrollment...
